Incyte, Glaxo Wellcome Ink Genomic Database Partnership Deal | GenomeWeb

PALO ALTO, Calif.--Incyte Pharmaceuticals has signed a multiyear genomic database partnership that will provide Glaxo Wellcome with access to specific LifeSeq database products in exchange for annual access fees, and could yield royalty payments to Incyte from sales of products developed with Incyte's products and database information.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.